BioMaster
AI overview
Sign in and the AI will write an overview from our coverage.
Headlines · 2
- Moonshot AI redirects Kimi toward science
The Decoder reports that Moonshot AI is redirecting its Kimi language models from coding toward biology, chemistry, and pharmaceutical research because the company sees diminishing returns in coding. Moonshot AI international director Giacomo Ficari said at the Web Summit in Lisbon that science demands smarter models than law, finance, or code. DP Technology is integrating Kimi K3.1 Pro into its research assistant BioMaster. In one partner test, the system analyzed gene data from 3,696 mouse pancreatic cells and flagged 100 candidate genes in 90 minutes, compared with an estimated four hours of human work. The report also notes that leading models produced verifiable proofs on TCSExam but solved no open conjectures alone. A June Citi survey of 50 US research leaders found that 24% expected AI to noticeably improve drug-development success rates.
The Decoder · 🔥 0 - Endless Frontier releases Fx-Bio-1031 bioinformatics model
Endless Frontier has released the full weights of Fx-Bio-1031, a bioinformatics model designed for professional tasks such as analyzing multi-omics data, writing analysis scripts, querying databases and validating results. The model is based on Qwen3.8-Flash-Next, supports tool use and local sandbox deployment, and has a native 512K context window. QbitAI reports that, in a team evaluation framework, Fx-Bio-1031 scored 70.59% Pass@5 on the Difficult subset of Anthropic's BioMysteryBench, compared with 47.06% for GPT-6-Astra and 52.94% for Claude Opus-5. It also recorded 89.50% Pass@3 on BiomniBench. The report attributes the comparison chart to a Hugging Face official evaluation and separately describes an internal independent validation system.
量子位(原生 RSS) · 🔥 0
Experience and discussion from the community
Share my BioMaster experienceAsk about BioMaster
Nobody has shared their experience with BioMaster yet.